Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 85.33B | 84.77B | 81.76B | 94.44B | 81.75B | 66.81B |
Gross Profit | 10.65B | 13.93B | 14.21B | 16.55B | 15.44B | 11.77B |
EBITDA | 9.78B | 7.57B | 10.81B | 12.73B | 11.69B | 8.54B |
Net Income | 3.38B | 3.33B | 3.68B | 5.36B | 5.05B | 2.98B |
Balance Sheet | ||||||
Total Assets | 71.63B | 69.88B | 66.81B | 68.28B | 63.59B | 55.31B |
Cash, Cash Equivalents and Short-Term Investments | 7.25B | 4.24B | 2.08B | 3.19B | 4.71B | 5.80B |
Total Debt | 0.00 | 24.21B | 20.83B | 20.22B | 19.02B | 18.35B |
Total Liabilities | 47.44B | 45.66B | 43.92B | 44.58B | 44.09B | 41.23B |
Stockholders Equity | 23.75B | 23.79B | 22.48B | 23.24B | 19.04B | 13.78B |
Cash Flow | ||||||
Free Cash Flow | 5.87B | 5.79B | 5.88B | 7.05B | 6.26B | 4.78B |
Operating Cash Flow | 8.73B | 8.72B | 9.26B | 10.96B | 9.99B | 7.70B |
Investing Cash Flow | -2.46B | -2.39B | -2.18B | -3.18B | -4.82B | -3.64B |
Financing Cash Flow | -4.52B | -6.35B | -6.90B | -7.41B | -6.22B | -2.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $14.29B | 11.67 | 15.68% | 3.82% | 13.41% | 10.00% | |
76 Outperform | $51.67B | 14.52 | 14.13% | 4.65% | 3.47% | -2.88% | |
75 Outperform | $54.81B | 13.56 | 14.69% | 2.54% | 0.27% | ― | |
74 Outperform | $15.29B | 18.54 | 37.70% | 1.35% | 24.07% | 27.40% | |
74 Outperform | $84.37B | 14.51 | 35.96% | 6.58% | 1.30% | -0.76% | |
70 Neutral | $11.63B | 23.54 | 32.11% | 2.53% | -0.22% | 65.52% | |
65 Neutral | $10.94B | 15.63 | 5.27% | 1.90% | 3.14% | -27.13% |